GlassScriptPhysician profile
Adeel H Mikael
NPI 1114238581
$35,992.77
in general payments reported to CMS, 2019-2025
14 companies · $92.29 in 2025
The $92.29 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2021: $179 · 2022: $245 · 2023: $21K · 2024: $14K · 2025: $92.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $8,625 · Consulting Fee: $4,200 · Food and Beverage: $2,703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,570.00 |
| Travel and Lodging | $8,625.05 |
| Consulting Fee | $4,200.00 |
| Food and Beverage | $2,703.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $34,883.51 | 2023-2025 | Veklury |
| Inari Medical, INC. | $165.11 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alkermes, INC. | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.39 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $122.04 | 2019 | |
| Melinta Therapeutics, LLC | $121.80 | 2019 | |
| Abbvie INC. | $121.13 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $119.86 | 2021 | |
| Mylan Specialty L.P. | $58.71 | 2021 | |
| Allergan, INC. | $57.50 | 2019 | |
| Abbott Laboratories | $34.10 | 2019 | |
| Mallinckrodt Hospital Products INC. | $33.90 | 2025 | Terlivaz |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.58 | 2025 | Lifevest |
| Pfizer INC. | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeel Mikael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.